Dual-pathway research blend

CJC/IPA

A 1:1 CJC-1295 and Ipamorelin blend for dual secretagogue pathway research.

Explore presentation-specific analytical records covering identity, purity, measured content, lot traceability and downloadable Certificates of Analysis.

Certified presentations
Product information
Royal Pharma CJC/IPA vial
Selected record5 / 5 mg

Product-family image supplied by Royal Pharma. Certified presentations are identified by their individual COA records below.

Product authentication

Authenticity, built into every product.

Powered by NFC. Secured by blockchain. Verified instantly.

Each Royal Pharma product carries a unique NFC-enabled microchip connected to the brand's proprietary blockchain authentication environment, creating a secure, traceable and tamper-resistant digital identity.

01
Unique identity

A product-linked NFC identity designed for one-tap verification.

02
Secure verification

A blockchain-secured record supporting authenticity and traceability.

03
Batch documentation

Presentation-specific COAs document identity, purity, measured content and lot information.

Product information

Two secretagogue pathways, documented in one sample.

CJC/IPA combines a short-acting GHRH analogue with the selective GHS-R1a agonist Ipamorelin. The supplied COA reports both identities and presentation-specific measured content for the submitted Royal Pharma sample.

01

Research class

GHRH analogue / GHS-R1a agonist blend
02

Documentation status

Investigational research blend
03

Reference CAS

Per component
04

Physical form

White lyophilised powder

Research profile

Two components. Two receptor routes.

The blend is used as a laboratory format for studying concurrent GHRH-receptor and ghrelin-receptor signalling. Evidence for the combined format remains research-based.

GHRH
CJC-1295 component

Provides the GHRH-analogue arm of the co-formulated research profile.

GHS-R1a
Ipamorelin component

Provides selective growth hormone secretagogue receptor activity in the blend.

1:1
Balanced formulation

The supplied presentation is documented as a 5 mg / 5 mg paired format.

Quality documentation

Certificate of Analysis

Choose a presentation to display the exact analytical record
supplied for that sample.

Select presentation
Selected COA

CJC/IPA · 5 / 5 mg

Purity99.912%
Measured content
Ipamorelin 5.95 mg / CJC-1295 6.10 mg
Identity
Ipamorelin / CJC-1295
Lot
109460
Appearance
White Lyophilized Powder
Accession number
2606282739
Search code
Received
02/21/2026
Reported
2/22/2026
For laboratory research use only.

The supplied certificates state that the tested materials are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications. Results are specific to the submitted samples. This page does not provide medical advice, dosing or administration instructions.